The similar results has been reported and published in Nature. Roche (Herceptin, HER2-antibody) should be one of secret party, they are too big to name on SPL reports. Btw, the critical utmost achievement for DEP is HER2-DEP, cause now Herceptin is confirmed as supporting chemotherapy, it just blocked the growth signals of cells, and prevent cancer recurrent rather than kill cancel cells.
So HER2-DEP-toxic cell drugs should be developed to fill the gaps.
SPL Price at posting:
79.0¢ Sentiment: Buy Disclosure: Held
